ABT compared with JNJ: revenue, margins and what each company keeps, and the suppliers and customers both name

ABTAbbott Laboratories

Mkt capRevenueRevenue

JNJJohnson & Johnson

Mkt capRevenueRevenue

Compare

ABTAbbott Laboratories

JNJJohnson & Johnson

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ABT

3 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 21 '26±5.3%▼−1.89%×0.36

Q2 FY26±4.3%▲+10.71%×2.49

Q1 FY26±4.4%▼−6.00%×1.36

Jan 22 '26±3.2%▼−10.04%×3.13

JNJ

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.1%▼−5.73%×1.84

Q2 FY26±2.9%▼−2.69%×0.93

= impliedABT realized, solidJNJ realized, hatchedOne scale, both sides: full bar = 11%× = |realized| ÷ impliedSource: market data

Q1 FY26

±3.0%

▲+0.90%

×0.30

Jan 21 '26±2.8%▼−0.09%×0.04

ABTAbbott Laboratories

109.43▼−0.67%· post 109.39

Mkt cap$190.6BRevenue$12.6BQ2 FY26Revenue$44.3BFY25

JNJJohnson & Johnson

266.16▼−1.63%· post 266.20

ClosedNov 3 '26

Mkt cap$651.3BRevenue$25.4BQ3 FY26Revenue$94.2BFY25

Compare

ClosedNov 3 '26

ABTAbbott Laboratories

JNJJohnson & Johnson

109.43▼−0.67%post 109.39

Price

266.16▼−1.63%post 266.20

$190.6B

Mkt cap

$651.3B

Q2 FY26$12.6B

Revenue

$25.4BQ3 FY26

FY25$44.3B

Revenue

$94.2BFY25

ABT109.43▼−0.67%vsJNJ266.16▼−1.63%ClosedNov 3 '26